Cargando…
Proprotein convertase subtilisin/kexin type 9: A new target molecule for gene therapy
Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as a novel target for controlling plasma levels of low-density lipoprotein cholesterol (LDL-C) and decreasing the risk of cardiovascular diseases. At present it is clear that the major classes of commonly prescribed lipid-lowering med...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SP Versita
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275701/ https://www.ncbi.nlm.nih.gov/pubmed/22311433 http://dx.doi.org/10.2478/s11658-012-0006-7 |